论文部分内容阅读
目的探讨尿激酶溶栓治疗对脑梗死患者的临床治疗效果。方法选择我院急性脑梗死患者80例,随机分为观察组和对照组。观察组给尿激酶溶栓治疗,对照组给予常规治疗。观察两组患者治疗前后神经功能缺损及血液流变学指标改变情况。结果观察组患者治疗后神经功能缺损评分较对照组治疗后显著降低(P<0.05)。观察组治疗后全血高切粘度、全血低切粘度、血浆比粘度改善情况优于对照组(P<0.05)。结论尿激酶溶栓治疗能够显著改善急性脑梗死患者神经功能缺损症状,有助于改善血流流变学指标,治疗效果显著,值得借鉴。
Objective To investigate the clinical effect of urokinase thrombolytic therapy on patients with cerebral infarction. Methods 80 patients with acute cerebral infarction in our hospital were randomly divided into observation group and control group. Observation group to urokinase thrombolytic therapy, control group given routine treatment. The changes of neurological deficits and hemorheological indexes before and after treatment in both groups were observed. Results The score of neurological deficit in observation group was significantly lower than that of control group after treatment (P <0.05). Observation group after treatment, whole blood viscosity, whole blood low shear viscosity, plasma viscosity than the control group improved (P <0.05). Conclusion Urokinase thrombolytic therapy can significantly improve the symptoms of neurological deficits in patients with acute cerebral infarction, help to improve the blood rheology, the treatment effect is significant, it is worth learning from.